Heart Attack Is No Accident: Why Biomarkers Like Apolipoprotein B Matter
Cardiovascular diseases are the number one cause of death in Germany, responsible for around 340,000 deaths annually. But contrary to popular belief, heart attacks are rarely a sudden event.
They are rather the result of a decades-long process called atherosclerosis, in which deposits form in the arteries and narrow them. This insidious process often goes unnoticed until a critical event occurs.
The Problem with Traditional Risk Assessments
Many preventive approaches focus on established laboratory values such as LDL cholesterol. While LDL values are undoubtedly important, they often do not provide a complete picture of individual risk.
It's paradoxical: Two people can have identical LDL values but carry completely different risks for cardiovascular disease. This is because LDL only measures cholesterol, not the number of actually vessel-damaging particles in the blood.
Apolipoprotein B: The Crucial Biomarker
This is where Apolipoprotein B (ApoB) comes into play. ApoB is a protein that attaches to the lipoproteins that transport cholesterol and other fats through the bloodstream. Each of these vessel-damaging particles contains exactly one ApoB molecule.
This means that the ApoB level in the blood directly reflects the number of atherogenic particles that can potentially damage the artery walls.
A high ApoB value signals a greater number of these harmful particles, even if the LDL cholesterol level is within the normal range. This makes ApoB a more precise indicator of the risk of atherosclerosis and thus of heart attacks and strokes.
Prevention Starts with Knowledge: Measure Early, Act Early
The good news is: Prevention is possible, but it starts with visibility of risks, long before symptoms become noticeable. If we know early on how many vessel-damaging particles are actually circulating in our blood, we can act proactively and take targeted measures to minimize the risk.
YOUspan enables fitness studios to provide their members with exactly these deep insights into their health. By integrating biomarker analyses like ApoB, studios can help their members better understand their individual risk and receive personalized recommendations for a healthier and longer life path.
Because: Those who measure early can act early and stay healthier in the long term.
References
[1] Robert Koch Institute, Destatis. (2024). Cardiovascular Diseases in Germany.